| Issues in performing a network meta-analysis S Senn, F Gavini, D Magrez, A Scheen Statistical Methods in Medical Research 22 (2), 169-189, 2013 | 76 | 2013 |
| Echocardiographic evidence for valvular toxicity of benfluorex: a double-blind randomised trial in patients with type 2 diabetes mellitus G Derumeaux, L Ernande, A Serusclat, E Servan, E Bruckert, H Rousset, ... PloS one 7 (6), e38273, 2012 | 33 | 2012 |
| Contemporary treatment patterns and response in relapsed/refractory cutaneous T-cell lymphoma (CTCL) across five European countries C Assaf, N Waser, M Bagot, M He, T Li, M Dalal, F Gavini, F Trinchese, ... Cancers 14 (1), 145, 2021 | 15 | 2021 |
| Real‐world treatment patterns and outcomes in non‐transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom M Mohty, W Knauf, D Romanus, S Corman, K Verleger, Y Kwon, ... European journal of haematology 105 (3), 308-325, 2020 | 13 | 2020 |
| Effectiveness of brentuximab vedotin monotherapy in relapsed or refractory Hodgkin lymphoma: a systematic review and meta-analysis WJ Plattel, A Bergamasco, F Trinchese, F Gavini, N Bent-Ennakhil, ... Leukemia & lymphoma 62 (14), 3320-3332, 2021 | 11 | 2021 |
| Effectiveness and safety of ixazomib-based therapy in relapsed/refractory multiple myeloma (RRMM) patients (pts) treated outside the clinical trial setting via an early access … H Ludwig, E Terpos, MV Mateos, M Boccadoro, B Kishore, K Ramasamy, ... Blood 136, 42-44, 2020 | 5 | 2020 |
| Real-world effectiveness of lanadelumab in European patients with HAE type I/II: Results from the retrospective integrated study M Magerl, L Bouillet, IM Saguer, F Gavini, I Andresen, N Bent-Ennakhil, ... ALLERGY 78, 146-146, 2023 | 1 | 2023 |
| First‐line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomes A Avigdor, F Trinchese, F Gavini, N Bent‐Ennakhil, M Dalal, A Zomas, ... EJHaem 3 (2), 415-425, 2022 | 1 | 2022 |
| Real-world treatment patterns and outcomes for patients with multiple myeloma in Denmark, Finland and Sweden: An analysis using linked Nordic registries N Abildgaard, P Anttila, A Waage, KH Rubin, S Ørstavik, N Bent-Ennakhil, ... European Journal of Cancer, 113921, 2024 | | 2024 |
| Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiveness and Safety of Ixazomib-based Therapy in Relapsed/Refractory Multiple Myeloma Outside of the Clinical Trial Setting H Ludwig, K Ramasamy, MV Mateos, B Kishore, V Gergely, M Ladicka, ... Clinical Lymphoma Myeloma and Leukemia 24 (2), e40-e49. e3, 2024 | | 2024 |
| Real-world burden of illness in patients with hereditary angioedema (HAE) type I and II H Farkas, E Aygoeren-Puersuen, A Kanani, F Psarros, D Ebo, NA Bara, ... ALLERGY 78, 149-149, 2023 | | 2023 |
| Second interim analysis of the'Use Via Early Access to Ixazomib'study: A European, multicentre, observational, longitudinal cohort study of the effectiveness and safety of … K Ramasamy, B Kishore, E Terpos, MV Mateos, M Boccadoro, ... BRITISH JOURNAL OF HAEMATOLOGY 193, 19-20, 2021 | | 2021 |
| 888MO Effectiveness of brentuximab vedotin in relapsed/refractory classic Hodgkin lymphoma: A systematic review and meta-analysis B Von Tresckow, A Bergamasco, F Trinchese, F Gavini, N Bent-Ennakhil, ... Annals of Oncology 31, S650, 2020 | | 2020 |
| 887MO Real-world treatment management of patients with advanced-stage classic Hodgkin lymphoma receiving front line therapy A Avigdor, F Trinchese, F Gavini, N Bent-Ennakhil, M Dalal, A Zomas, ... Annals of Oncology 31, S649-S650, 2020 | | 2020 |
| REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILISATION, AND CLINICAL OUTCOMES FROM THE HUMANS STUDY IN MULTIPLE MYELOMA IN DENMARK, SWEDEN, AND FINLAND N Abildgaard, M Hansson, P Anttila, A Waage, A Green, KH Rubin, ... | | 2020 |
| Treatment patterns and real-life response in patients with relapsed/refractory cutaneous t-cell lymphoma: clinical practice data in Spain P Ortiz-Romero, N Pimpinelli, TM Illidge, M Bagot, N Waser, M He, ... | | 2020 |
| Real-World Treatment Patterns from the HUMANS Study in Multiple Myeloma in Denmark N Abildgaard, A Waage, M Hansson, P Anttila, M Szilcz, Y Ma, KH Rubin, ... Blood 134, 5030, 2019 | | 2019 |
| Utilizing Multiple Linked Populations Registers to Estimate Incidence and Prevalence of Multiple Myeloma in Sweden and Denmark from the Real-World HUMANS Study M Hansson, N Abildgaard, A Waage, P Anttila, A Green, KH Rubin, ... Blood 134, 5037, 2019 | | 2019 |
| PS1416 EVOLVING TREATMENT PATTERNS IN NON-STEM CELL TRANSPLANT (NSCT) NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS FROM A REAL-WORLD CHART REVIEW IN FRANCE, GERMANY, AND THE UK M Mohty, D Romanus, K Verleger, Y Kwon, S Corman, D Cherepanov, ... HemaSphere 3 (S1), 651, 2019 | | 2019 |
| PS1256 CONTEMPORARY TREATMENT PATTERNS AND RESPONSE IN RELAPSE/REFRACTORY CUTANEOUS T‐CELL LYMPHOMA (CTCL) IN CLINICAL PRACTICE IN FRANCE, GERMANY ITALY, SPAIN AND THE UNITED … T Illidge, M Bagot, N Waser, M He, T Li, R Sambrook, Z Athanasios, ... HemaSphere 3, 573-574, 2019 | | 2019 |
